172 related articles for article (PubMed ID: 20472046)
1. Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics.
Rawat A; Burgess DJ
Int J Pharm; 2010 Jul; 394(1-2):99-105. PubMed ID: 20472046
[TBL] [Abstract][Full Text] [Related]
2. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
3. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
[TBL] [Abstract][Full Text] [Related]
4. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
5. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
Uchida T; Yagi A; Oda Y; Goto S
J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
[TBL] [Abstract][Full Text] [Related]
6. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.
Leo E; Pecquet S; Rojas J; Couvreur P; Fattal E
J Microencapsul; 1998; 15(4):421-30. PubMed ID: 9651864
[TBL] [Abstract][Full Text] [Related]
7. Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents.
Wang FJ; Wang CH
J Control Release; 2002 Jun; 81(3):263-80. PubMed ID: 12044566
[TBL] [Abstract][Full Text] [Related]
8. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
9. Effect of acidic pH on PLGA microsphere degradation and release.
Zolnik BS; Burgess DJ
J Control Release; 2007 Oct; 122(3):338-44. PubMed ID: 17644208
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres.
Zolnik BS; Burgess DJ
J Control Release; 2008 Apr; 127(2):137-45. PubMed ID: 18282629
[TBL] [Abstract][Full Text] [Related]
11. Ammonolysis-based microencapsulation technique using isopropyl formate as dispersed solvent.
Im HY; Sah H
Int J Pharm; 2009 Dec; 382(1-2):130-8. PubMed ID: 19715744
[TBL] [Abstract][Full Text] [Related]
12. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
Doan TV; Couet W; Olivier JC
Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123
[TBL] [Abstract][Full Text] [Related]
13. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
14. Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods.
Kawashima Y; Yamamoto H; Takeuchi H; Hino T; Niwa T
Eur J Pharm Biopharm; 1998 Jan; 45(1):41-8. PubMed ID: 9689534
[TBL] [Abstract][Full Text] [Related]
15. Nanostructured microspheres produced by supercritical fluid extraction of emulsions.
Della Porta G; Reverchon E
Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122
[TBL] [Abstract][Full Text] [Related]
16. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
[TBL] [Abstract][Full Text] [Related]
17. A novel preparation method for PLGA microspheres using non-halogenated solvents.
Matsumoto A; Kitazawa T; Murata J; Horikiri Y; Yamahara H
J Control Release; 2008 Aug; 129(3):223-7. PubMed ID: 18562036
[TBL] [Abstract][Full Text] [Related]
18. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
Doan TV; Olivier JC
Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
[TBL] [Abstract][Full Text] [Related]
19. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug.
D'Aurizio E; van Nostrum CF; van Steenbergen MJ; Sozio P; Siepmann F; Siepmann J; Hennink WE; Di Stefano A
Int J Pharm; 2011 May; 409(1-2):289-96. PubMed ID: 21356295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]